SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-047595
Filing Date
2024-04-24
Accepted
2024-04-24 16:15:17
Documents
12
Period of Report
2024-04-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bcab-20240422.htm   iXBRL 8-K 45136
2 EX-3.1 bcab-ex3_1.htm EX-3.1 246172
  Complete submission text file 0000950170-24-047595.txt   446061

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20240422.xsd EX-101.SCH 24844
16 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20240422_htm.xml XML 4697
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 24870753
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)